Each year, Colorado BioScience Association highlights our life sciences ecosystem with our annual magazine. CBSA member companies, academic and research institutions, and partners collaborate to improve lives here in Colorado and around the world. This annual publication celebrates our global impact, shared successes, and provides data on clinical trials and regulatory milestones achieved by our ecosystem.
We designed the annual magazine in printed and digital format as a resource for members and partners to share with potential investors and prospective business partners or send to out-of-state candidates for leadership positions. Please let our team know if you need paper copies of the magazine.
Colorado BioScience Association members drive global health innovations, products, and services that improve and save lives. Their dedication and passion inspires us.
Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify patients that are cured of lymphoma during treatment, eliminating unnecessary chemotherapy and dramatically improving quality of life. Foresight does this by using the world's most sensitive cancer surveillance technology to detect cancer relapse up to 100 days sooner than current testing methods.
Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how and experience from the pharmaceutical industry to develop medicines for significant unmet medical needs. Exxel is focused on the development of small-molecule therapeutics for safe, non-addictive treatment of pain, PTSD, and substance (e.g. opioid) use disorders.
CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific oversight, full-service clinical research, and collaborative support. The impact goes beyond research and continues into community implementation through their Community Health programs.
PhosphoSolutions specializes in producing high-quality research antibodies for the neuroscience community. The company’s research antibodies provide critical information on drug effectiveness that drives scientific breakthroughs.
The Colorado Molecular Correlates Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cancer treatments with targeted therapy allowing for the best in personalized medicine. Focusing on quality is key to the lab’s success and work to save lives.
Cerebral Therapeutics is dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The company is addressing chronic neurological diseases using novel and proprietary drugs administered directly to the fluid around the brain. With a newly launched Phase 2b study, Cerebral credits its mission-driven culture and strong relationships with scientists and clinicians at the CU Anschutz Medical Campus as critical to the company's success.
Neurexis Therapeutics relies on innovation to address a substantial unmet medical need:damage to the brain resulting from loss of blood flow during stroke, cardiac arrest, and other events. The company's goal is to advance a neuroprotective drug that prevents impairment and improves patients' lives. Less than a year since forming, Neurexis is propelling forward with progress.
Z Biotech is a leading biotech company providing the most advanced microarray products and quality services for glycomics research. They contribute leading carbohydrate products and services to biotech and pharmaceutical companies and research institutes worldwide. Through integrity of research, team selfawareness and their community, Z Biotech has made strides in 2020.
Alpha Omega Alpha Honor Medical Society (AΩA) aims to improve the medical profession and care for all through education, teaching, leadership, humanism, and community service. AΩA is the nation’s only interdisciplinary honor medical society providing $2 million annually in grants, fellowships, awards, and programs to medical faculty and students, and mid-career physicians.
IMD Path is an integrated Molecular Diagnostics Laboratory with enabling pathology and empowering oncology offering state-of-the-art technology and testing capabilities. With out of the box creative design, and a strong culture, IMD Path focuses on the individual contribution to the overall mission to deliver best in class, quality, and accurate testing.
ClinImmune Labs is a network of innovators and dedicated visionaries that specialize in cell therapy and gene therapy. A pioneer in stem cell therapy, ClinImmune recognizes their team brings a unique ecosystem to the work that pushes successes to the next level, saving more patients lives across several countries and reaching more advances in scientific discoveries.
ArtisanBio creates customized cell engineering solutions to solve the most challenging problems in human health applications. By leveraging rapid advances in DNA reading and writing technologies at the interface of engineering and biology, Artisan delivers more efficacious and safe cell products to the market. Their team is built on an environment of innovation and talent.
The DARTNet Institute (DI) has facilitated partnerships between practice-based research networks, academic health centers, clinicians, and patients. The institute leverages existing electronic data and the expansion of patient or staff-reported data for research, quality improvement, and safety.
Avidity finds creative fuel at Fitzsimons Innovation Community. An expert in bioluminescent technologies, the company develops molecular affinity tools for connecting molecules. Avidity products are sold worldwide, including to research institutions investigating treatments for COVID-19.
Three women now make up half of the company’s C-level team. To accelerate growth, the women made tough decisions about major changes at the company, which focuses on blood-based diagnostics to help doctors evaluate and treat non-small cell lung cancer.
Colorado attracts biotech pioneers. Leaders of i2 Pharmaceuticals say the state's innovation environment allows smart, motivated people to make a name for themselves. The Boulder company works with major drug manufacturers for support solving the drug discovery puzzle.
Today, AlloSource’s work focuses on regenerative medicine and the potential power of cellular technologies, making the company the world’s largest processor of cellular allografts for transplant and the leading provider of skin allografts for burn survivors.